Dr. Zev Aryeh Wainberg, MD

Dr. Wainberg practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Wainberg's NPI, 1104850932, was assigned on July 10, 2006. Dr. Wainberg graduated from Tel Aviv University Sackler in 2000. Dr. Wainberg holds California license A82044.

Dr. Wainberg's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Wainberg's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Wainberg is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Wainberg to 3 more group practices and clinics, 2 medical groups, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wainberg practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wainberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wainberg is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Wainberg's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, fluid and electrolyte imbalances and multiple myeloma among the conditions Dr. Wainberg treats.

CMS data shows 111,101 Medicare services from Dr. Wainberg across 42 procedure codes in 2024, for 387 Medicare patients. Medicare paid $451,949 for them.

CMS counts 387 Medicare patients who saw Dr. Wainberg in 2024. The largest group is 65 to 74, with 197 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wainberg's median patient age at 68, with 49% women.

In 2024, Dr. Wainberg wrote 135 Medicare Part D claims for 57 patients. 87% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $209,747 in total drug cost. In 2021, CMS named 48 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wainberg for performance year 2024, reported as part of a group. Dr. Wainberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wainberg as offering telehealth.

Dmand AI links 142 papers to Dr. Wainberg, published from 2012 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Stomach Neoplasms and Antibodies, Monoclonal, Humanized. Dr. Wainberg has published most often in J Clin Oncol. Dr. Wainberg's most frequent co-authors are Daniel V. Catenacci, Yelena Y. Janjigian, MD and Charles Stewart Fuchs, MD, MPH.

Dmand AI links Dr. Wainberg to 16 clinical trials, 5 of them phase 1 studies. Conditions studied include Rectal Diseases, Adenocarcinoma Of Esophagus and Neoplasm Metastasis. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Wainberg that name 4 trials.

CMS Open Payments shows 663 general payments to Dr. Wainberg from 38 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Merck Sharp & Dohme Corporation paid the most, $258,681. It also lists 17 research payments totaling $28,300 from 2016 to 2025, naming 4 clinical trials.

Dr. Wainberg graduated from Tel Aviv University Sackler in 2000.

Dr. Wainberg is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.